LAUREN SKURKA: Open Payments
NPI 1134601206 · HOBART, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$590 in 28 payments from 11 companies in 2025. Trend: 2023 $0 · 2024 $0 · 2025 $590
Food & beverage: $590
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 4 | $103 |
| LEO Pharma Inc. | 5 | $97 |
| Lilly USA, LLC | 3 | $73 |
| Novartis Pharmaceuticals Corporation | 3 | $63 |
| UCB, Inc. | 2 | $55 |
| ABBVIE INC. | 3 | $44 |
| Regeneron Healthcare Solutions, Inc. | 2 | $42 |
| GENZYME CORPORATION | 2 | $39 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 2 | $31 |
| Amgen Inc. | 1 | $24 |
Products named: TREMFYA, ADBRY, DUPIXENT, Bimzelx, EBGLYSS, SKYRIZI, Winlevi, Rhapsido.
Industry payments across IN — which companies pay providers there.
